Middle East Too Reliant On Imports?

April 2006 | Company Finance Alert

Despite posting steady growth in recent years, industry observers are warning that the pharmaceuticals market in the Middle East is still too dependent on imports and lacks sufficient scientific R&D centres. According to a recent study by BusinessIntelligence Middle East (BIME), Israel imports 60% of its pharmaceuticals, Jordan (70%), Saudi Arabia (80%) and Lebanon (94%). It is hoped that a surge of investment in new manufacturing facilities, especially in markets such as the UAE, but also Jordan, Egypt and Lebanon will help to reduce this dependency.

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.